Psychiatry

814 questions

Question 121Question →

A 75-year-old man is brought to the neurology clinic by his son. Over the past 8 months, the patient has developed a progressively unsteady gait. The son describes his father's walking as feeling "glued to the ground" with very short steps. For the past 4 months, the patient has had difficulty managing his finances, exhibits new-onset apathy, and struggles with short-term memory. Over the last month, he has had multiple episodes of urinary incontinence, toward which he appears indifferent. His medical history includes hypertension and type 2 diabetes mellitus. Neurological examination reveals a broad-based, magnetic gait, but muscle strength and deep tendon reflexes are normal. A magnetic resonance imaging (MRI) scan of the brain is obtained and is shown below, demonstrating enlarged lateral and third ventricles with relatively normal, uncrowded cortical sulci. What is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: High-volume lumbar puncture

Answer

High-volume lumbar puncture
The correct answer is a high-volume lumbar puncture. The patient presents with the classic triad of Normal Pressure Hydrocephalus (NPH): abnormal gait (magnetic, broad-based, 'glued to the floor'), cognitive impairment, and urinary incontinence. Neuroimaging confirms communicating hydrocephalus, showing ventriculomegaly without significant cortical atrophy. The most appropriate next step in management is a high-volume lumbar puncture (also known as the tap test or Miller Fisher test) to remove 30-50 mL of cerebrospinal fluid. Improvement in gait and cognitive function following this procedure confirms the diagnosis and indicates that the patient is likely to benefit from definitive surgical treatment with a ventriculoperitoneal shunt.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's presentation.
The patient exhibits the classic triad of gait apraxia ('magnetic' gait), cognitive impairment, and urinary incontinence.
Recognizing this specific symptom triad is essential for suspecting Normal Pressure Hydrocephalus (NPH).
2
Analyze the neuroimaging findings provided in the vignette.
The MRI shows ventriculomegaly out of proportion to cortical atrophy.
This confirms communicating hydrocephalus and supports the diagnosis of NPH over ex vacuo ventriculomegaly, which is typically seen in neurodegenerative diseases like Alzheimer's.
3
Determine the next best step in the diagnostic and management pathway.
A high-volume lumbar puncture (Miller Fisher tap test) is indicated.
Removing 30-50 mL of cerebrospinal fluid assesses whether the patient's gait and cognitive symptoms temporarily improve, which strongly predicts the success of definitive surgical treatment.

Key Concept

Diagnosis and management of Normal Pressure Hydrocephalus (NPH)
Estimated Time:1m 0s
Question 122Question →

A 30-year-old male chef is brought to the emergency department by his husband due to worsening suicidal ideation. For the past month, the patient has experienced profound sadness, a 7-kg (15-lb) weight gain, hypersomnia, and a complete lack of energy. He has a history of major depressive disorder diagnosed in his early twenties. His husband reports that three years ago, the patient had a 3-week period where he slept only two hours per night, spoke so rapidly he was difficult to interrupt, and developed grandiose delusions that he had discovered the cure for aging. These delusions completely resolved when his mood returned to baseline. The patient is currently not taking any prescribed medications but consumes a high-dose St. John's wort supplement daily. Vital signs are within normal limits. Mental status examination reveals a cooperative patient with depressed mood, flattened affect, and psychomotor retardation. He denies current hallucinations or delusions. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate lurasidone

Answer

Initiate lurasidone
This patient's history of a distinct period of decreased need for sleep, rapid speech, and grandiose delusions is diagnostic of a prior manic episode. Because the psychotic symptoms (delusions) resolved concurrently with the mood symptoms, the correct diagnosis is Bipolar I Disorder, not schizoaffective disorder. He is currently presenting with an acute bipolar depressive episode. First-line pharmacotherapy for acute bipolar depression includes specific second-generation antipsychotics such as lurasidone, quetiapine, or cariprazine. Lurasidone effectively targets the depressive symptoms without carrying the high risk of inducing a manic switch.

Step-by-Step Solution

1
Analyze the patient's past psychiatric history.
The patient had a distinct 3-week period of decreased sleep, rapid speech, and grandiose delusions that resolved with his mood.
Identifying past episodes of mania or hypomania is required to differentiate bipolar disorder from major depressive disorder.
2
Determine the correct diagnosis.
The history of a manic episode establishes a diagnosis of Bipolar I Disorder. The current presentation is an acute depressive episode.
The presence of delusions during the manic episode indicates bipolar disorder with psychotic features. Because the psychosis did not occur outside the mood episode, schizoaffective disorder is ruled out.
3
Select the appropriate pharmacotherapy.
Lurasidone is selected as it is a first-line agent for acute bipolar depression.
Antidepressant monotherapy must be avoided to prevent a manic switch, and potential drug interactions with St. John's wort must be considered.

Key Concept

Patients with Bipolar I Disorder presenting with an acute depressive episode should be treated with mood stabilizers or specific second-generation antipsychotics (e.g., lurasidone, quetiapine) to avoid the high risk of antidepressant-induced manic switch.
Question 123Question →

A 28-year-old man comes to the outpatient clinic for a routine psychiatric follow-up. He has a history of major depressive disorder, for which he takes sertraline. During the session, the patient appears visibly agitated, pacing the room and speaking loudly about his recent job termination. He states, "My former boss is completely ruining my life. Sometimes I get so furious that I just want to kill him." The physician immediately asks if the patient has any specific plan or true intent to harm his former boss. The patient sits down, shakes his head, and says, "No, of course not. I am just venting because I am so frustrated. I would never actually hurt anyone or risk going to jail." Further assessment reveals he has no access to firearms and no prior history of violent behavior. He denies any current suicidal ideation. Vital signs are within normal limits. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Maintain patient confidentiality and continue the outpatient psychiatric evaluation

Answer

Maintain patient confidentiality and continue the outpatient psychiatric evaluation.
The correct answer is to maintain patient confidentiality and continue the outpatient psychiatric evaluation. The physician's duty to protect third parties from a patient (often referred to as the Tarasoff duty) is triggered only when the patient presents a serious, imminent danger of violence to a specific, identifiable victim. In this scenario, although the patient expresses anger and a vague wish to harm his boss, he explicitly denies any intent or plan, has no access to weapons, and states he is "just venting." Therefore, the threshold for imminent danger is not met. Breaching confidentiality in this situation is legally and ethically contraindicated; the physician should carefully document the risk assessment and continue standard outpatient care.

Step-by-Step Solution

1
Analyze the patient's statements for the risk of imminent violence.
The patient expressed homicidal ideation ("want to kill him") but explicitly denied any intent, plan, or access to weapons when queried.
Risk assessment is required whenever a patient makes threatening statements to determine if emergency intervention is needed.
2
Apply the legal and ethical threshold for the duty to warn or protect.
The threat is not imminent or actionable because there is no specific plan or true intent to carry out violence.
The Tarasoff ruling mandates breaching confidentiality only when a patient presents a serious, imminent danger to a specific, identifiable victim.
3
Determine the most appropriate management step based on the risk assessment.
Because the threshold for breaching confidentiality or initiating an involuntary hold is not met, the physician must respect the patient's privacy and proceed with standard care.
Unnecessary breaches of confidentiality violate medical ethics and federal law (HIPAA).

Key Concept

The duty to warn or protect (Tarasoff ruling) requires breaching medical confidentiality ONLY when a patient presents an explicit, imminent threat of serious harm to a specific, identifiable third party.
Question 124Question →

A 58-year-old man is brought to the clinic by his wife due to an 88-month history of progressive behavioral changes. His wife reports that he has become increasingly apathetic and socially withdrawn, frequently neglecting his personal hygiene. He recently began compulsively hoarding empty glass bottles and has made sexually explicit remarks to neighbors, which is entirely out of character. The patient has a history of bipolar I disorder following a single manic episode at age 22, but he has been euthymic and off psychiatric medications for over 3030 years. Mental status examination reveals an alert and oriented patient with a blunted affect. He displays poor insight and disinhibition during the interview. Memory recall is 3/3 after 55 minutes, but he exhibits significant impairment on the Trail Making Test Part B. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 0.2μU/mL0.2 \mu U/mL (Normal: 0.4−4.0μU/mL0.4-4.0 \mu U/mL) and a free thyroxine (T4) level of 0.6ng/dL0.6 ng/dL (Normal: 0.9−1.7ng/dL0.9-1.7 ng/dL). The patient has a legally executed advance directive designating his eldest daughter as his sole healthcare proxy. However, the daughter is not present, and the wife vehemently demands the physician immediately start an antidepressant, believing his symptoms represent a severe depressive relapse. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Obtain structural magnetic resonance imaging of the brain

Answer

Obtain structural magnetic resonance imaging of the brain
The correct action is to obtain a structural MRI of the brain. The patient presents with classic clinical features of behavioral variant frontotemporal dementia (bvFTD), characterized by early changes in personality, apathy, disinhibition, compulsive behaviors, and significant executive dysfunction with relative sparing of memory and visuospatial skills. Additionally, his laboratory results reveal central hypothyroidism (low TSH and low Free T4). The combination of a frontal lobe syndrome and a central pituitary/hypothalamic endocrinopathy should immediately raise suspicion for a structural brain lesion, such as a large frontal meningioma or tumor compressing the pituitary stalk, alongside primary neurodegenerative etiologies. An MRI is the most definitive next step to rule out space-occupying, vascular, or structural causes of his decline.

Step-by-Step Solution

1
Analyze the neurocognitive presentation and timeline.
The patient demonstrates new-onset apathy, disinhibition, hoarding, and executive dysfunction with preserved memory, highly suspicious for behavioral variant frontotemporal dementia (bvFTD).
Identifying the primary neurocognitive syndrome is essential for guiding the diagnostic workup.
2
Evaluate the laboratory findings.
TSH and Free T4 are both below normal limits, indicating central hypothyroidism.
These findings suggest a central hypothalamic-pituitary axis disruption rather than primary thyroid failure.
3
Synthesize clinical and laboratory data to determine the next step.
The combination of frontal lobe signs (bvFTD phenotype) and central endocrinopathy (central hypothyroidism) highly suggests a structural brain lesion (e.g., a frontal mass compressing the pituitary stalk) or a significant neurodegenerative process.
New-onset major neurocognitive disorders with atypical features or concurrent central endocrinopathies mandate neuroimaging to rule out reversible or structural causes.
4
Review the ethical constraints regarding surrogate decision-making.
The patient lacks capacity, and the daughter is the designated healthcare proxy. The wife's demands cannot override the legal proxy.
Medical interventions should only proceed with the consent of the legally appointed surrogate when an advance directive exists.

Key Concept

Patients presenting with new-onset major neurocognitive disorder featuring atypical symptoms (e.g., prominent frontal lobe behavioral changes) and concurrent objective medical abnormalities (e.g., central hypothyroidism) require prompt structural brain imaging to evaluate for potentially reversible or space-occupying lesions.
Estimated Time:1m 30s
Question 125Question →

A 32-year-old man is brought to the emergency department by emergency medical services after his roommate found him lethargic with empty pill bottles nearby. The patient states he intentionally ingested "a handful" of his prescribed phenelzine and his roommate's fluoxetine two hours ago because he "wanted to sleep forever." Vital signs are temperature 39.1°C (102.4°F), blood pressure 165/100 mmHg, heart rate 122/min, and respiratory rate 20/min. Physical examination reveals profuse diaphoresis, bilateral ocular clonus, and hyperreflexia most prominent in the lower extremities. As the physician prepares to initiate treatment, the patient becomes agitated, states he has changed his mind about wanting to die, and demands to leave the hospital immediately. He explicitly forbids the physician from contacting his wife, stating, "If she finds out about this, she will take my kids away." Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Place an involuntary psychiatric hold and administer cyproheptadine

Answer

Place an involuntary psychiatric hold and administer cyproheptadine
The correct answer addresses both the acute medical emergency and the psychiatric/legal components of the presentation. Medically, the patient is experiencing severe Serotonin Syndrome due to the ingestion of phenelzine (a monoamine oxidase inhibitor) and fluoxetine (a selective serotonin reuptake inhibitor). This diagnosis is supported by the triad of autonomic instability (hyperthermia, tachycardia), altered mental status, and prominent neuromuscular irritability (hyperreflexia, ocular clonus). The definitive pharmacological antidote for severe Serotonin Syndrome is cyproheptadine, a serotonin antagonist. Psychiatrically and legally, the patient lacks decision-making capacity. His judgment is severely impaired by the acute suicide attempt and toxic encephalopathy. Even though he claims to have 'changed his mind,' a patient who has just taken a lethal overdose cannot safely be allowed to leave against medical advice. The physician has a legal and ethical duty to place an involuntary emergency psychiatric hold to prevent imminent harm and provide life-saving treatment.

Step-by-Step Solution

1
Assess the patient's decision-making capacity regarding his request to leave against medical advice.
The patient lacks capacity because his judgment is impaired by an acute suicide attempt and toxic encephalopathy.
A patient actively experiencing a life-threatening toxidrome from a suicide attempt is presumed to lack capacity, necessitating an involuntary emergency hold to prevent imminent self-harm.
2
Diagnose the medical toxidrome based on the history of medication ingestion and physical examination findings.
The combination of an MAOI (phenelzine), an SSRI (fluoxetine), hyperthermia, autonomic instability, and neuromuscular hyperactivity (clonus, hyperreflexia) strongly indicates Serotonin Syndrome.
Identifying the correct toxidrome is critical for selecting the appropriate pharmacological reversal agent.
3
Determine the legal and ethical requirements for treatment consent and confidentiality.
Apply the doctrine of implied consent to administer life-saving cyproheptadine, and maintain confidentiality regarding his wife.
In a life-threatening emergency where capacity is impaired, physicians must provide immediate treatment without waiting for a surrogate. Breaching confidentiality is only justified if there is a threat to a specific third party.

Key Concept

Management of Serotonin Syndrome in the setting of acute suicidality and impaired capacity
Question 126Question →

A 26-year-old female graduate student is brought to the emergency department by her roommate. For the past month, the patient has exhibited profound sadness, a 4.5-kg (10-lb) weight loss, and severe psychomotor retardation. She sleeps 14 hours a day and refuses to attend her classes. During the interview, she stares blankly and admits she has been hearing a persistent voice saying she is "a fraud who deserves to die." The roommate reports that two years ago, the patient had a distinct 3-week period where she barely slept, spoke incredibly fast, bought thousands of dollars of unneeded laboratory equipment on credit, and claimed she had independently deciphered the human genome. That prior episode culminated in a 5-day psychiatric hospitalization. Her urine toxicology screen is negative. Which of the following is the most accurate diagnosis and most appropriate initial pharmacotherapy for this patient?

Show answer & explanation

Answer: Bipolar I disorder; initiate quetiapine

Answer

The most accurate diagnosis is Bipolar I disorder, and the most appropriate treatment is to initiate quetiapine.
The correct answer accurately identifies that a single lifetime episode of mania (characterized by grandiosity, decreased sleep, rapid speech, and hospitalization) is sufficient to diagnose Bipolar I disorder, regardless of the current presentation. Because the patient is currently in a severe depressive episode with psychotic features, treatment must target both mood stabilization and psychosis. Quetiapine is a second-generation antipsychotic with robust, FDA-approved efficacy in acute bipolar depression, and it will simultaneously manage her auditory hallucinations without the risk of precipitating a manic switch.

Step-by-Step Solution

1
Analyze the patient's psychiatric history from two years ago.
The history of a 3-week period of elevated mood, grandiosity, decreased need for sleep, and hospitalization indicates a severe manic episode.
Identifying any lifetime history of mania is required to correctly differentiate bipolar I disorder from unipolar major depressive disorder.
2
Evaluate the patient's current clinical presentation.
The patient exhibits depressed mood, significant weight loss, hypersomnia, psychomotor retardation, and auditory hallucinations for 1 month, indicating an acute major depressive episode with mood-congruent psychotic features.
Establishing the current phase of the bipolar illness dictates the immediate pharmacological intervention.
3
Select a safe and effective pharmacotherapy for the current diagnosis.
Quetiapine is selected over antidepressant monotherapy or isolated mood stabilizers.
Antidepressant monotherapy is contraindicated in bipolar disorder due to the risk of inducing a manic switch. An atypical antipsychotic like quetiapine is FDA-approved for bipolar depression and will concurrently address the psychotic features.

Key Concept

Patients presenting with acute depression must be screened for a history of mania or hypomania to rule out Bipolar Disorder. Antidepressant monotherapy is contraindicated in bipolar depression due to the risk of manic switch; first-line treatments include quetiapine, lurasidone, or olanzapine-fluoxetine combination.
Question 127Question →

A 34-year-old woman presents to the clinic with a 6-week history of profound sadness, anhedonia, and terminal insomnia. She reports significant functional impairment, having recently taken a leave of absence from her job due to a severe inability to concentrate. Review of systems is notable for a 4.5-kg (10-lb) weight loss and mild psychomotor agitation. Thorough psychiatric screening confirms the absence of any past manic or hypomanic episodes, ruling out bipolar disorder. Over the next 14 months, her major depressive disorder exhibits a complex trajectory, requiring a progressive, stepped-care escalation of her management plan according to standard psychiatric guidelines. Arrange the following clinical interventions in the most appropriate chronological sequence, beginning with her initial presentation and escalating to the management of life-threatening psychiatric complications.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of management is: (1) Initiate a first-line SSRI, (2) Titrate the SSRI to the maximum dose for inadequate response, (3) Switch to a different antidepressant class for complete non-response, (4) Augment with a second-generation antipsychotic for partial response, and (5) Proceed with ECT for life-threatening complications.
The standard stepped-care algorithm for major depressive disorder prioritizes single-agent optimization before increasing complexity. Treatment begins with initiating a first-line agent, such as an SSRI. If the initial dose yields inadequate results after an appropriate timeframe (4-6 weeks), the dose must be optimized to the maximum tolerated level. If there is a complete lack of response to the optimized dose, switching to a different class (e.g., SNRI) is indicated to target different neurotransmitters. If a subsequent trial results in a partial response, augmenting with a second agent (e.g., aripiprazole, lithium) is preferred to build on the existing improvement. Finally, if the depression becomes completely treatment-resistant and progresses to life-threatening symptoms (such as active suicidality or food refusal), electroconvulsive therapy (ECT) becomes the urgent intervention of choice.

Step-by-Step Solution

1
Initiate pharmacotherapy with a first-line SSRI.
Establishes baseline pharmacotherapy for the acute depressive episode.
SSRIs are the first-line standard of care for uncomplicated major depressive disorder after ruling out bipolar disorder.
2
Titrate the initial SSRI to the maximum tolerated dose.
Achieves the maximum potential therapeutic effect of the initial agent.
Premature discontinuation is a common error; a trial must be optimized to maximum tolerated doses for at least 4-6 weeks before being declared a failure.
3
Cross-titrate to an antidepressant with a different mechanism of action (e.g., SNRI).
Switches the neurochemical target to overcome complete non-response.
Switching classes is preferred over augmentation when there is a complete lack of response to an optimized initial monotherapy trial.
4
Augment the second antidepressant with a second-generation antipsychotic.
Builds upon the partial clinical improvement achieved by the second agent.
Augmentation is the preferred evidence-based strategy when the current agent provides partial efficacy, avoiding the loss of partial gains that might occur with another switch.
5
Proceed with electroconvulsive therapy (ECT).
Provides definitive, rapid symptom relief for treatment-resistant depression.
ECT becomes necessary and life-saving when treatment-resistant depression progresses to include emergent complications like food refusal, catatonia, or active suicidality.

Key Concept

Stepped-care treatment escalation for major depressive disorder.
Question 128Question →

A 7272-year-old woman is brought to the geriatrics clinic by her husband due to progressive memory loss and confusion over the past 33 months. Her husband states she spends most of her day in bed, has stopped cooking, and has lost 55 kg (1111 lb). Over the last 33 weeks, she has been repeatedly stating that "the government is coming to arrest me for tax fraud," which is completely unfounded.

Past medical history is significant for Parkinson disease, treated with selegiline, and bipolar I disorder. She previously took lithium but discontinued it a year ago of her own volition.

On mental status examination, she exhibits marked psychomotor retardation and poor eye contact. When asked to perform serial sevens or spell "WORLD" backwards, she gives minimal effort, frequently stating, "I don't know, my mind is completely gone."

Her daughter, who is her legally appointed healthcare proxy, lives in another state. Her husband is frustrated with the patient's decline and demands that the physician immediately authorize her placement in a local nursing home.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Recommend inpatient psychiatric admission for electroconvulsive therapy

Answer

Recommend inpatient psychiatric admission for electroconvulsive therapy
The correct response is to recommend inpatient psychiatric admission for electroconvulsive therapy. This patient is experiencing a severe bipolar depressive episode with psychotic features, which is presenting as pseudodementia. Key indicators of pseudodementia include a relatively rapid onset, highlighting of cognitive deficits, and poor effort on testing (giving 'I don't know' answers), unlike true neurocognitive disorders where patients often attempt to conceal their deficits. Given her severe depression, psychotic features, poor oral intake (weight loss), and complex medication history (recent MAOI use), electroconvulsive therapy (ECT) is the safest and most rapidly effective treatment. Additionally, ECT is known to transiently improve the motor symptoms of Parkinson disease.

Step-by-Step Solution

1
Analyze the patient's cognitive and behavioral presentation.
The relatively rapid onset of symptoms, poor effort on cognitive testing ('I don't know' answers), and severe depressive features indicate pseudodementia rather than a true major neurocognitive disorder.
Differentiating between dementia and depression-induced cognitive impairment is critical for appropriate management.
2
Evaluate the patient's psychiatric symptoms and history.
The presence of delusions (tax fraud) and a history of bipolar I disorder indicate a severe bipolar depressive episode with psychotic features.
Psychotic depression requires aggressive and specific interventions, often involving combination pharmacotherapy or somatic therapies.
3
Assess the medication history for pharmacological contraindications.
The patient takes selegiline, an MAOI, which strictly contraindicates SSRI use due to serotonin syndrome risk. Additionally, her bipolar history contraindicates antidepressant monotherapy.
Recognizing dangerous drug-drug interactions prevents iatrogenic harm.
4
Determine the optimal treatment step while navigating ethical constraints.
Electroconvulsive therapy (ECT) is the safest and most rapidly effective treatment. The husband's demand for nursing home placement must be deferred to the daughter, who is the legally appointed proxy.
ECT is the gold standard for severe psychotic depression in the elderly, particularly when complicated by poor oral intake and Parkinson disease. Legally, the proxy's authority cannot be bypassed.

Key Concept

Discriminating pseudodementia from true neurocognitive disorders and identifying appropriate management (ECT) while avoiding pharmacological contraindications and adhering to surrogate decision-making laws.
Question 129Question →

A 54-year-old software developer with no prior psychiatric history is evaluated for Major Depressive Disorder (MDD). Arrange the following pharmacological and somatic management steps in the correct chronological sequence according to standard stepped-care escalation protocols, starting from the initial presentation to the eventual management of a severe, life-threatening refractory state.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of treatment escalation for MDD is: 1) Initiate SSRI monotherapy, 2) Switch to an SNRI for non-response, 3) Augment with an atypical antipsychotic for partial response, and 4) Administer ECT for life-threatening treatment-resistant depression.
The correct stepped-care escalation for major depressive disorder begins with SSRI monotherapy. If there is no response, switching to a different antidepressant (like an SNRI) is indicated. If there is a subsequent partial response, augmentation (e.g., with an atypical antipsychotic) is preferred to maximize the partial gains. Finally, if the patient becomes completely treatment-resistant and develops life-threatening complications like food refusal, ECT is the definitive, rapid-acting treatment of choice.

Step-by-Step Solution

1
Identify the appropriate first-line treatment for an initial MDD diagnosis.
Initiation of an SSRI.
SSRIs have a favorable side-effect profile and are the universally recommended starting point for uncomplicated MDD.
2
Determine the best management strategy for a patient who shows absolutely no response to the first-line agent after an adequate trial.
Switch to an alternative monotherapy (e.g., an SNRI).
Switching minimizes polypharmacy and is preferred when the initial drug provides zero benefit.
3
Determine the next step if the second agent provides only partial symptom relief.
Augmentation with an adjunctive agent like an atypical antipsychotic.
Augmentation builds upon the partial response already achieved without having to cross-taper and risk losing those partial gains.
4
Identify the definitive treatment for refractory depression that has become acutely life-threatening.
Electroconvulsive therapy (ECT).
ECT provides rapid, definitive treatment for severe depression complicated by immediate physical risks such as starvation from food refusal.

Key Concept

The stepped-care approach to Major Depressive Disorder involves initiating first-line monotherapy, switching agents for complete non-response, augmenting for partial response, and utilizing somatic therapies like ECT for severe, treatment-resistant, or life-threatening disease.
Question 130Question →

A 34-year-old man with a history of treatment-resistant depression is brought to the emergency department by his partner. The patient was doing well on a newly prescribed psychiatric medication until this morning, when he took an over-the-counter nasal decongestant for a severe cold. Within an hour of taking the cold medication, he developed a severe, throbbing headache, blurred vision, and neck stiffness. On triage, his temperature is 37.1°C (98.8°F), pulse is 115/min, and blood pressure is 220/125 mm Hg. Physical examination shows diaphoresis and normal deep tendon reflexes without clonus. Which of the following psychiatric medications is this patient most likely taking?

Show answer & explanation

Answer: Phenelzine

Answer

Phenelzine
The correct psychiatric medication is an MAOI, such as phenelzine. Monoamine oxidase inhibitors (MAOIs) work by irreversibly inhibiting the enzyme monoamine oxidase, thereby preventing the breakdown of monoamines including serotonin, norepinephrine, and dopamine. When a patient taking an MAOI consumes a sympathomimetic drug, such as pseudoephedrine or phenylephrine found in over-the-counter nasal decongestants, it triggers a massive release or accumulation of catecholamines. This classically precipitates a sudden and potentially life-threatening hypertensive crisis, presenting with markedly elevated blood pressure, severe throbbing headache, diaphoresis, and neck stiffness. The absence of hyperreflexia and clonus helps rule out serotonin syndrome.

Step-by-Step Solution

1
Identify the patient's acute clinical syndrome based on the physical examination and vitals.
The patient is experiencing a sudden, severe hypertensive crisis (blood pressure 220/125 mm Hg) accompanied by a throbbing headache and diaphoresis, without clonus or hyperreflexia.
Establishing the specific toxidrome narrows down the possible pathophysiologic mechanisms.
2
Determine the inciting trigger for the hypertensive crisis.
The symptoms began immediately after taking an over-the-counter nasal decongestant, which contains sympathomimetics like pseudoephedrine or phenylephrine.
Identifying the precipitating agent is necessary to recognize the specific drug-drug interaction.
3
Match the drug interaction with the appropriate class of psychiatric medications.
Monoamine oxidase inhibitors (MAOIs) interact dangerously with sympathomimetics, leading to excessive catecholamines and resulting in a hypertensive crisis.
This confirms which psychiatric drug class causes this classic presentation.

Key Concept

Drug-drug interactions involving Monoamine Oxidase Inhibitors (MAOIs) and sympathomimetics leading to hypertensive crisis.
Estimated Time:1m 0s
Question 131Question →

For each clinical presentation described below, select the most appropriate personality disorder diagnosis.

Click a left item, then click its matching right item

Items

Patient A: A 24-year-old woman exhibits intense mood swings, chronic feelings of emptiness, and a pattern of unstable interpersonal relationships. She recently made self-injurious gestures after her therapist announced a brief vacation.
Patient B: A 31-year-old man actively chooses to work as a solitary night watchman. He demonstrates no desire for close relationships, including romantic ones, and appears completely indifferent to both the praise and criticism of his manager.
Patient C: A 36-year-old physician repeatedly demands that administrators create a dedicated parking spot specifically for him, citing his unique brilliance. He dismisses nursing staff contributions and reacts with intense rage when a colleague questions his approach.
Patient D: A 29-year-old man experiences significant social anxiety and attributes minor everyday events to hidden, special meanings directed at him. He dresses eccentrically and claims he can sense the auras of people around him.

Matches

Show answer & explanation

Answer

Patient A corresponds to Borderline personality disorder. Patient B corresponds to Schizoid personality disorder. Patient C corresponds to Narcissistic personality disorder. Patient D corresponds to Schizotypal personality disorder.
Each clinical vignette provides distinctive DSM-5 criteria that allow for the direct identification of the underlying condition. Patient A exhibits classic borderline traits (Cluster B), Patient B shows schizoid traits (Cluster A), Patient C demonstrates narcissistic traits (Cluster B), and Patient D displays schizotypal traits (Cluster A).

Step-by-Step Solution

1
Analyze Patient A's presentation for defining criteria.
Identified fear of abandonment, self-harm, and unstable relationships.
These traits are specific to borderline personality disorder in Cluster B.
2
Analyze Patient B's presentation for defining criteria.
Identified a genuine preference for isolation and emotional detachment.
These traits distinguish schizoid personality disorder (Cluster A) from other conditions.
3
Analyze Patient C's presentation for defining criteria.
Identified grandiosity, entitlement, and rage in response to perceived criticism.
These are the diagnostic hallmarks of narcissistic personality disorder in Cluster B.
4
Analyze Patient D's presentation for defining criteria.
Identified magical thinking, ideas of reference, and eccentric appearance.
These symptoms characterize schizotypal personality disorder in Cluster A.

Key Concept

Differentiating personality disorders based on core DSM-5 diagnostic criteria.
Question 132Question →

A 31-year-old woman is evaluated in the clinic for severe mood changes. She delivered her first child 5 months ago without complications. Over the past 8 weeks, she has experienced profound sadness, anhedonia, and a 5-kg (11-lb) weight loss. She awakens at 3:00 AM daily and cannot return to sleep. She notes her depressed mood is worst in the mornings and is completely unreactive to positive events, including playing with her infant. Two weeks ago, her primary care physician prescribed escitalopram; however, she discontinued it 4 days ago, stating it was ineffective. Her husband reports that five years ago, she had a 7-day episode where she slept only 2 hours per night, spoke incessantly, and compulsively purchased thousands of dollars of baby clothes despite not being pregnant. She has no other medical conditions and does not use illicit substances. Vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Begin treatment with quetiapine

Answer

Begin treatment with quetiapine
The correct action is to begin treatment with quetiapine. This patient presents with a major depressive episode featuring melancholic characteristics. However, her history of a 7-day period of decreased sleep, pressured speech, and severe impulsivity establishes a diagnosis of Bipolar I disorder. The standard of care for bipolar depression includes atypical antipsychotics such as quetiapine or lurasidone, or mood stabilizers like lithium, to treat the depression without risking a manic switch.

Step-by-Step Solution

1
Identify the current clinical syndrome from the patient's presentation.
The patient is currently experiencing a major depressive episode with melancholic features, characterized by anhedonia, early morning awakenings, unreactive mood, and significant weight loss occurring in the postpartum period.
Establishing the current episode dictates the immediate need for psychiatric intervention.
2
Evaluate the patient's psychiatric history for previous mood episodes.
The husband describes a distinct past episode of decreased need for sleep, pressured speech, and severe impulsivity lasting 7 days, which meets the criteria for a manic episode.
A history of mania completely changes the diagnostic framework from unipolar depression to bipolar disorder.
3
Formulate the correct diagnosis and select the appropriate pharmacotherapy.
The diagnosis is Bipolar I disorder, currently in a depressed episode. The most appropriate treatment is an atypical antipsychotic approved for bipolar depression, such as quetiapine or lurasidone.
Antidepressant monotherapy is contraindicated in bipolar disorder due to the high risk of inducing a manic switch.

Key Concept

Patients presenting with a major depressive episode must be screened for a history of mania or hypomania; if present, the diagnosis is bipolar disorder, and treatment requires a mood stabilizer or approved atypical antipsychotic rather than antidepressant monotherapy.
Question 133Question →

A 2222-year-old college student is brought to the emergency department by his roommate due to severe agitation and bizarre behavior. The roommate reports that for the past 22 weeks, the patient has barely slept, paced the room continuously, and claimed that government agents are monitoring his thoughts. The roommate found empty plastic baggies containing residual white powder on the patient's desk. The patient has a history of major depressive episodes and is currently prescribed sertraline. His family history is notable for a mother with bipolar disorder. In the emergency department, the patient is combative, diaphoretic, and uncooperative. Temperature is 38.2∘C38.2^\circ \text{C} (100.8∘F100.8^\circ \text{F}), blood pressure is 165/100 mmHg165/100 \text{ mmHg}, pulse is 128/min128/\text{min}, and respirations are 22/min22/\text{min}. Physical examination reveals bilaterally dilated pupils and a fine resting tremor. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous lorazepam

Answer

Administer intravenous lorazepam
The correct action is to administer intravenous lorazepam. This patient presents with a classic sympathomimetic toxidrome resulting from acute stimulant intoxication (likely cocaine or amphetamines, given the white powder). The presentation includes severe psychomotor agitation, paranoia, hyperthermia, hypertension, tachycardia, diaphoresis, and mydriasis. The immediate priority in severe stimulant intoxication is to control agitation and sympathetic hyperactivity to prevent life-threatening complications such as myocardial infarction, arrhythmias, or seizures. Benzodiazepines (e.g., lorazepam, diazepam) are the first-line agents because they safely sedate the patient, reduce central sympathetic outflow, decrease heart rate and blood pressure, and increase the seizure threshold.

Step-by-Step Solution

1
Identify the patient's toxidrome from the clinical presentation.
The combination of severe psychomotor agitation, paranoia, hyperthermia, hypertension, tachycardia, diaphoresis, and mydriasis indicates sympathomimetic toxicity (e.g., cocaine or amphetamine intoxication).
Recognizing the pattern of vital sign abnormalities and physical exam findings is essential to differentiate stimulant intoxication from primary psychiatric disorders or other ingestions.
2
Determine the immediate medical priorities.
The primary goal is to safely sedate the patient, lower the cardiovascular demand, and raise the seizure threshold.
Uncontrolled sympathetic overdrive can lead to fatal arrhythmias, myocardial infarction, intracranial hemorrhage, or status epilepticus.
3
Select the appropriate pharmacotherapy.
Benzodiazepines, such as lorazepam, are administered to achieve the management goals.
Benzodiazepines enhance GABA-ergic inhibition in the central nervous system, effectively reversing the stimulant-induced agitation and sympathetic excess.

Key Concept

The first-line treatment for acute stimulant (sympathomimetic) intoxication with severe agitation is the administration of benzodiazepines.
Question 134Question →

Emergency medical responders bring a 3232-year-old woman, who is at 2828 weeks gestation, to the emergency department after she was found wandering in traffic. The patient has a history of schizoaffective disorder and stopped taking her medications 33 months ago. On arrival, she is actively vomiting large amounts of bright red blood. Vital signs are temperature 37.1∘C37.1^\circ\text{C}, pulse 135/min135/\text{min}, respirations 24/min24/\text{min}, and blood pressure 80/50 mmHg80/50\text{ mmHg}. She is extremely agitated, striking at the nursing staff, and screaming, "The doctors are vampires trying to steal my baby's soul!" She physically resists all attempts at medical intervention. The physician determines she lacks the capacity to make medical decisions due to acute psychosis.

The patient's sister, who is her legally appointed healthcare proxy, arrives at the emergency department. The sister provides a signed, notarized advance directive that the patient completed 55 years ago during a period of psychiatric stability. The document explicitly states: "I refuse the administration of any blood products under all circumstances due to my religious convictions." The sister states, "I know what the document says, but she is pregnant and bleeding to death. As her proxy, I am authorizing you to give her the blood transfusion to save her and the baby."

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Withhold the blood transfusion in accordance with the advance directive and resuscitate with intravenous crystalloids.

Answer

Withhold the blood transfusion in accordance with the advance directive and resuscitate with intravenous crystalloids.
The correct answer involves respecting the patient's autonomy as documented in a valid advance directive. When a patient currently lacks capacity (in this case, due to acute psychosis and hemorrhagic shock), medical decisions must be guided by their previously stated wishes. A written advance directive created while the patient had capacity is the most authoritative representation of those wishes. Healthcare proxies exercise substituted judgment and are legally bound to follow the advance directive; they cannot override it, even in life-threatening emergencies. Furthermore, the ethical principle of bodily autonomy dictates that a pregnant woman's valid refusal of medical treatment must be upheld in the United States, even if it jeopardizes the life of a viable fetus. Therefore, the physician must honor the refusal of blood products and attempt to stabilize the patient using alternative methods, such as intravenous crystalloids.

Step-by-Step Solution

1
Assess the patient's current decision-making capacity.
The patient lacks capacity to refuse or consent to treatment due to acute psychosis and hemodynamic instability.
An actively psychotic patient who incorporates the medical staff into her delusions cannot demonstrate understanding of the risks and benefits of the proposed intervention.
2
Identify the highest-ranking legal source of decision-making.
A valid, notarized advance directive exists, which explicitly refuses blood products.
An advance directive created during a period of documented capacity serves as the most authoritative representation of the patient's autonomous wishes.
3
Evaluate the surrogate's authority to override the document.
The sister's consent is invalid for the blood transfusion.
A healthcare proxy is designated to implement the patient's wishes (substituted judgment). They do not have the legal authority to contradict a clear, specific, and valid advance directive.
4
Evaluate maternal-fetal ethical obligations in the context of treatment refusal.
The maternal refusal of care (via the advance directive) must be respected despite the viability of the fetus.
In the United States, a pregnant patient's right to bodily autonomy and refusal of medical treatment supersedes the state's interest in protecting the fetus.

Key Concept

Hierarchy of Surrogate Decision-Making and Maternal-Fetal Ethics
Question 135Question →

A 42-year-old woman is brought to the emergency department by her husband due to worsening confusion, severe nausea, vomiting, and a prominent hand tremor. Her husband reports that she has been unusually unsteady on her feet for the past three days. Her medical history is significant for bipolar disorder, which has been well-controlled on a stable dose of lithium for the past five years. Three weeks ago, she was diagnosed with essential hypertension by her primary care provider and was started on a new daily medication. On physical examination, the patient is lethargic and exhibits a coarse resting tremor, hyperreflexia, and ataxia. Her serum lithium level is 2.1 mEq/L (therapeutic range: 0.6-1.2 mEq/L). Which of the following antihypertensive medications was most likely prescribed to this patient?

Show answer & explanation

Answer: Hydrochlorothiazide

Answer

Hydrochlorothiazide
The correct answer is hydrochlorothiazide. This patient is experiencing acute lithium toxicity, characterized by gastrointestinal symptoms, coarse tremor, ataxia, and confusion, confirmed by an elevated serum lithium level. Lithium is almost entirely excreted by the kidneys. Thiazide diuretics (such as hydrochlorothiazide) inhibit sodium reabsorption in the distal convoluted tubule, leading to mild hypovolemia. This volume depletion stimulates the kidneys to increase sodium reabsorption in the proximal convoluted tubule. Because lithium is handled similarly to sodium by the kidneys, lithium reabsorption is concurrently increased in the proximal tubule. This leads to decreased lithium clearance and a rapid accumulation of the drug to toxic levels. Other common medications that precipitate lithium toxicity include NSAIDs, ACE inhibitors, and ARBs.

Step-by-Step Solution

1
Identify the patient's acute clinical presentation.
The patient presents with confusion, ataxia, coarse tremor, and gastrointestinal distress, confirmed by an elevated serum lithium level of 2.1 mEq/L.
Recognizing the clinical syndrome of lithium toxicity is the essential first step in determining its underlying cause.
2
Correlate the toxicity with recent changes in medical management.
The toxicity began shortly after starting a new antihypertensive medication three weeks ago.
Lithium has a narrow therapeutic index, and its serum levels are highly sensitive to concurrent medications that alter renal function.
3
Determine which class of antihypertensives decreases lithium clearance.
Thiazide diuretics (like hydrochlorothiazide) are classic agents that decrease renal lithium clearance and precipitate toxicity.
Thiazides cause mild volume depletion, triggering a compensatory increase in proximal tubular reabsorption of sodium and lithium.

Key Concept

Lithium has a narrow therapeutic index and is almost exclusively cleared by the kidneys. Its renal clearance is significantly decreased by concurrent use of thiazide diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and angiotensin-converting enzyme (ACE) inhibitors, which can rapidly lead to potentially fatal toxicity.
Question 136Question →

A physician at a community health clinic evaluates a 34-year-old man who reports feeling "constantly tense and detached" for the past half-year. Seven months ago, the patient survived a severe factory explosion in which two of his colleagues died. Since the incident, he experiences recurrent, vivid nightmares about the explosion and becomes visibly diaphoretic and tachycardic whenever he hears loud metallic noises. He has completely stopped driving near the industrial park where he used to work and mentions that he feels entirely disconnected from his wife and children. His medical history is significant for treatment-resistant major depressive disorder, for which his psychiatrist prescribed tranylcypromine three weeks ago after multiple other medication trials failed. His blood pressure is 128/82 mm Hg, and his pulse is 76/min. The patient expresses a strong desire for immediate relief from his hyperarousal and intrusive memories. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate trauma-focused cognitive behavioral therapy

Answer

Initiate trauma-focused cognitive behavioral therapy
The patient's presentation of intrusive nightmares, severe physiological reactivity to triggers, avoidance behavior, and emotional detachment lasting for 7 months following a life-threatening event is diagnostic of post-traumatic stress disorder (PTSD). First-line treatments for PTSD include trauma-focused cognitive behavioral therapy (TF-CBT) and serotonergic antidepressants (SSRIs or SNRIs). Because this patient is currently taking tranylcypromine, a monoamine oxidase inhibitor (MAOI), the addition of an SSRI or SNRI is absolutely contraindicated due to the high risk of developing life-threatening serotonin syndrome. Therefore, initiating a non-pharmacologic first-line treatment such as TF-CBT is the safest and most appropriate next step in management.

Step-by-Step Solution

1
Establish the correct psychiatric diagnosis based on symptom duration and clinical presentation.
The patient meets the criteria for Post-Traumatic Stress Disorder (PTSD) because his symptoms of intrusion, avoidance, and hyperarousal have persisted for 7 months.
Acute stress disorder resolves or transitions to PTSD after 1 month. The prolonged timeline confirms PTSD.
2
Identify the standard first-line treatment options for PTSD.
First-line therapies include trauma-focused cognitive behavioral therapy (TF-CBT) and pharmacotherapy with SSRIs or SNRIs.
Both psychological and pharmacological approaches have strong, evidence-based efficacy in reducing the core symptoms of PTSD.
3
Evaluate the patient's current medication regimen for potential life-threatening drug interactions.
The patient is taking tranylcypromine, an MAOI. Concomitant use of MAOIs and serotonergic antidepressants (SSRIs/SNRIs) is strictly contraindicated.
Combining these medications can cause fatal serotonin syndrome. Furthermore, safely switching from an MAOI to a serotonergic agent requires a 14-day washout period.
4
Select the most appropriate, safe, and immediate next step in management.
Initiate trauma-focused cognitive behavioral therapy.
TF-CBT provides first-line efficacy for PTSD without risking dangerous drug interactions with the patient's active MAOI regimen.

Key Concept

Management of Post-Traumatic Stress Disorder (PTSD) in the setting of concurrent MAOI therapy
Estimated Time:1m 30s
Question 137Question →

A 48-year-old man is evaluated in the outpatient clinic for a 6-week history of persistently low mood, severe fatigue, anhedonia, and waking up at 3:00 AM every day without being able to return to sleep. He reports feeling "completely empty" and has unintentionally lost 4.5 kg4.5\text{ kg} (10 lb10\text{ lb}) over this period. His past medical history is significant for chronic lumbar radiculopathy, for which he takes daily tramadol. His past psychiatric history reveals a psychiatric hospitalization at age 32 for a 3-week episode of abnormally euphoric mood, hypersexuality, decreased need for sleep, and impulsive spending that led to significant debt. Vital signs are within normal limits. Physical examination is unremarkable. Mental status examination reveals a disheveled man with psychomotor retardation, restricted affect, and depressed mood. He denies active suicidal ideation. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.8 μU/mL1.8\text{ }\mu\text{U/mL} and a free thyroxine (T4) level of 1.2 ng/dL1.2\text{ ng/dL}. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate lurasidone

Answer

The most appropriate next step is to initiate lurasidone, a second-generation antipsychotic approved for bipolar depression.
The patient's current presentation of low mood, anhedonia, weight loss, and early morning awakenings meets the criteria for a major depressive episode. However, his history of a prior hospitalization for euphoric mood, decreased need for sleep, and impulsivity is highly characteristic of a manic episode. Therefore, his correct diagnosis is bipolar I disorder, currently in a depressed episode. The standard of care for acute bipolar depression includes specific second-generation antipsychotics (e.g., lurasidone, quetiapine, cariprazine) or mood stabilizers (e.g., lithium, lamotrigine). Initiating lurasidone is the most appropriate next step to effectively treat his depressive symptoms without the risk of inducing mania.

Step-by-Step Solution

1
Identify the patient's current clinical syndrome.
The patient is presenting with a major depressive episode (low mood, fatigue, anhedonia, early morning awakening, weight loss).
Establishing the current phase of the illness is necessary to guide symptom-specific therapy.
2
Review the patient's past psychiatric history.
The patient has a history of a distinct manic episode at age 32 (euphoria, hypersexuality, decreased sleep, impulsive spending requiring hospitalization).
A history of mania changes the diagnosis from major depressive disorder to bipolar I disorder.
3
Select the appropriate pharmacotherapy for bipolar depression while avoiding contraindications.
Lurasidone is selected over antidepressant monotherapies (which risk manic switch) and over medications that interact with his current regimen.
Lurasidone is approved for acute bipolar depression. Antidepressants like sertraline or venlafaxine are avoided as monotherapy in bipolar I disorder. Selegiline is avoided due to interactions with tramadol.

Key Concept

Patients presenting with depressive episodes must be screened for a history of mania; if present, the diagnosis is bipolar I disorder, and treatment involves mood stabilizers or specific atypical antipsychotics (e.g., lurasidone, quetiapine) rather than antidepressant monotherapy.
Question 138Question →

A 78-year-old man residing in an assisted living facility is evaluated for a decline in his cognitive abilities over the past 3 months. The nursing staff report that he has stopped participating in social activities, frequently stays in his room with the blinds drawn, and has lost 4.5 kg (10 lb) during this period. When asked about his memory, the patient becomes distressed and repeatedly states, "My mind is completely gone; I cannot remember anything anymore." On cognitive testing, he makes poor eye contact and frequently responds to questions with "I don't know," exhibiting minimal effort. However, when strongly encouraged by the examiner, he successfully performs complex attention tasks. His neurological examination shows no focal deficits. A non-contrast head CT performed 2 months ago after a mechanical fall was unremarkable. Laboratory studies, including thyroid-stimulating hormone and vitamin B12, are within normal limits. Which of the following is the most appropriate initial management for this patient?

Show answer & explanation

Answer: Initiate sertraline therapy

Answer

The most appropriate initial management is to initiate sertraline therapy.
The patient is exhibiting signs of major depressive disorder (MDD) presenting with prominent cognitive impairment, a condition historically referred to as pseudodementia. In elderly patients, MDD frequently manifests with cognitive deficits, psychomotor retardation, and neurovegetative symptoms such as weight loss and social withdrawal. Key features that differentiate MDD from a progressive major neurocognitive disorder (e.g., Alzheimer disease) include a relatively rapid, identifiable onset, the patient's acute awareness of and distress regarding their memory loss, and a tendency to give 'I don't know' answers on cognitive testing. Furthermore, when encouraged, these patients can often complete complex tasks, demonstrating intact underlying cognition. The most appropriate initial step in management is to treat the underlying depression with a selective serotonin reuptake inhibitor (SSRI) such as sertraline, which typically leads to improvement in both mood and cognitive symptoms.

Step-by-Step Solution

1
Analyze the time course and character of the cognitive decline.
The patient has a 3-month history of cognitive decline accompanied by social withdrawal and weight loss.
Establishing the timeline helps differentiate between the insidious onset of neurodegenerative dementias and the subacute onset typical of mood disorders or delirium.
2
Evaluate the patient's performance and attitude during cognitive testing.
The patient shows significant distress about memory loss, frequently answers with 'I don't know', but performs well when actively encouraged.
These testing behaviors are hallmark signs of depression-related cognitive impairment. In contrast, patients with Alzheimer disease often lack insight into their deficits and attempt to cover them up (confabulation).
3
Determine the most appropriate initial therapy based on the primary diagnosis.
The clinical picture is consistent with major depressive disorder, indicating the need for an antidepressant such as an SSRI (sertraline).
Treating the underlying unipolar depression will likely lead to improvement in both the patient's mood and cognitive deficits.

Key Concept

Depression-related cognitive impairment (historically called pseudodementia) presents with a subacute onset of memory issues, prominent distress regarding cognitive deficits, and frequent 'I don't know' responses on testing. Treatment involves addressing the underlying depression with antidepressants such as SSRIs.
Question 139Question →

Match each patient's clinical presentation with the most appropriate first-line management strategy or pharmacological principle.

Click a left item, then click its matching right item

Items

A 2222-year-old woman with a normal body mass index presents with hypochloremic metabolic alkalosis, parotid hypertrophy, and dental enamel erosion.
A 3131-year-old man with a body mass index of 34 kg/m234 \text{ kg/m}^2 experiences marked distress over recurrent episodes of rapidly eating uncomfortably large amounts of food, without engaging in compensatory behaviors.
A 1919-year-old woman with a body mass index of 14.5 kg/m214.5 \text{ kg/m}^2 exhibits an intense fear of gaining weight, amenorrhea, and engages in daily self-induced vomiting.
A 4545-year-old woman experiences persistent health anxiety and spends excessive time worrying about multiple diffuse joint and abdominal pains, despite completely normal medical evaluations.

Matches

Show answer & explanation

Answer

Bulimia nervosa matches with fluoxetine/bupropion contraindication; Binge-eating disorder matches with cognitive-behavioral therapy and lisdexamfetamine; Anorexia nervosa matches with nutritional rehabilitation priority; Somatic symptom disorder matches with regular, scheduled primary care visits.
Each clinical vignette describes a unique psychiatric disorder requiring a highly specific initial management step. Bulimia nervosa is managed with cognitive-behavioral therapy and fluoxetine, and bupropion is strictly contraindicated due to electrolyte-induced seizure risk. Binge-eating disorder is effectively treated with cognitive-behavioral therapy and lisdexamfetamine. Anorexia nervosa necessitates urgent nutritional rehabilitation and weight restoration above all pharmacological options. Somatic symptom disorder is best managed by establishing a therapeutic alliance with one primary care provider via regular, scheduled visits to avoid iatrogenic harm from repeated diagnostic testing.

Step-by-Step Solution

1
Diagnose the patient in each vignette based on their clinical features and physical parameters.
Patient 1 has Bulimia Nervosa (normal weight, purging signs). Patient 2 has Binge-Eating Disorder (obesity, bingeing without purging). Patient 3 has Anorexia Nervosa, binge-eating/purging type (severe underweight, fear of weight gain, purging). Patient 4 has Somatic Symptom Disorder (persistent somatic symptoms, high anxiety, normal workups).
Accurate psychiatric diagnosis is the prerequisite for selecting the appropriate disease-specific management algorithm.
2
Identify the primary treatment or critical pharmacological principle specific to each diagnosed disorder.
Bulimia: Fluoxetine is first-line, bupropion is contraindicated. Binge-Eating Disorder: CBT and lisdexamfetamine. Anorexia: Nutritional rehabilitation is the immediate priority. Somatic Symptom Disorder: Scheduled follow-ups with a single provider.
Each disorder in the somatic symptom and eating disorder spectrum has a distinct, standard-of-care intervention pathway that must be accurately applied.

Key Concept

Diagnosis and tailored management of somatic symptom and eating disorders
Question 140Question →

A 42-year-old male is admitted for an acute exacerbation of schizophrenia and is started on intramuscular haloperidol. Three days later, he develops severe, generalized muscle rigidity, profound diaphoresis, and mutism. His temperature is 103.8°F (39.9°C), pulse is 122/min, respirations are 24/min, and blood pressure is 178/104 mm Hg. Physical examination reveals "lead-pipe" rigidity in all extremities. Laboratory studies reveal a serum creatine kinase level of 5,500 U/L. Based on standard clinical guidelines, arrange the following management steps in the correct sequential order from the most immediate initial intervention to the most advanced treatment reserved for refractory cases.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard sequence of management for neuroleptic malignant syndrome begins with immediately discontinuing the antipsychotic, followed by supportive care, then targeted pharmacotherapy if needed, and finally electroconvulsive therapy for refractory cases.
Neuroleptic malignant syndrome (NMS) is a life-threatening psychiatric emergency typically triggered by high-potency first-generation antipsychotics like haloperidol. The management follows a well-defined escalation pathway. The absolute first step is stopping the offending agent. Subsequent management is hierarchical based on severity and clinical response. Aggressive supportive care (including intravenous hydration to prevent acute kidney injury from rhabdomyolysis, and physical cooling) is the primary medical intervention and should be instituted immediately after drug cessation. If the patient does not respond adequately to supportive measures, or if the initial presentation is extremely severe, pharmacotherapy with dopamine agonists (e.g., bromocriptine, amantadine) or ryanodine receptor antagonists (e.g., dantrolene) is indicated. Finally, for cases that are highly refractory to all medical interventions, or if lethal catatonia cannot be ruled out, electroconvulsive therapy (ECT) is the definitive treatment of last resort.

Step-by-Step Solution

1
Identify the life-threatening psychiatric emergency.
The patient's presentation of fever, lead-pipe rigidity, autonomic instability, and elevated creatine kinase after starting haloperidol indicates Neuroleptic Malignant Syndrome (NMS).
Accurate diagnosis is required to initiate the specific life-saving protocol rather than treating isolated symptoms.
2
Determine the first, most immediate intervention.
Discontinuation of the offending antipsychotic agent.
Further exposure to the dopamine antagonist will worsen the condition; removing the trigger is the absolute prerequisite for recovery.
3
Determine the subsequent sequence of escalating interventions based on clinical guidelines.
Supportive care must precede specific antidotes, and ECT is reserved for the end of the algorithm.
Supportive care (IV fluids, cooling) prevents fatal complications like renal failure. Pharmacotherapy (bromocriptine, dantrolene) is added for moderate-to-severe cases. ECT is the definitive treatment only if medical management fails.

Key Concept

The progressive management of Neuroleptic Malignant Syndrome (NMS) follows a strict stepwise algorithm: immediate discontinuation of the offending agent, followed by supportive medical care, targeted pharmacotherapy, and lastly electroconvulsive therapy for refractory cases.
PreviousPage 7 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 7 | Examkin